63(top 2%)
papers
1.1K(top 2%)
citations
17(top 2%)
h-index
33(top 2%)
g-index
67
all documents
1.3K
doc citations
596
citing journals

Top Articles

#TitleJournalYearCitations
1Socioeconomic status as an effect modifier of alcohol consumption and harm: analysis of linked cohort dataLancet Public Health, The2017218
2Effectiveness and cost effectiveness of cardiovascular disease prevention in whole populations: modelling studyBMJ: British Medical Journal2011149
3Evidence synthesis for constructing directed acyclic graphs (ESC-DAGs): a novel and systematic method for building directed acyclic graphsInternational Journal of Epidemiology202077
4Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) reviewHealth Technology Assessment201468
5Are financial incentives cost-effective to support smoking cessation during pregnancy?Addiction201661
6Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchersTrials201552
7Oral versus intravenous antibiotic treatment for bone and joint infections (OVIVA): study protocol for a randomised controlled trialTrials201548
8Long-Term Effects of Statin Treatment in Elderly People: Extended Follow-Up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)PLoS ONE201341
9Following the science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemicBMC Medicine202139
10An evaluation of the effects of lowering blood alcohol concentration limits for drivers on the rates of road traffic accidents and alcohol consumption: a natural experimentLancet, The201937
11Economic analysis of the health impacts of housing improvement studies: a systematic reviewJournal of Epidemiology and Community Health201328
12Cost‐utility analysis of deep brain stimulation surgery plus best medical therapy versus best medical therapy in patients with Parkinson's: Economic evaluation alongside the PD SURG trialMovement Disorders201627
13Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCTHealth Technology Assessment201927
14P105 Prevalence and associated factors of musculoskeletal joint disease in the community setting in Hai district, northern TanzaniaRheumatology202227
15Mapping from the Parkinson’s Disease Questionnaire PDQ-39 to the Generic EuroQol EQ-5D-3LMedical Decision Making201526
16Explaining trends in alcohol-related harms in Scotland, 1991–2011 (I): the role of incomes, effects of socio-economic and political adversity and demographic changePublic Health201621
17TRANSCATHETER AORTIC VALVE IMPLANTATION FOR SEVERE AORTIC STENOSIS: THE COST-EFFECTIVENESS CASE FOR INOPERABLE PATIENTS IN THE UNITED KINGDOMInternational Journal of Technology Assessment in Health Care201320
18Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa TherapyJAMA Neurology202220
19Patient acceptability of three different central venous access devices for the delivery of systemic anticancer therapy: a qualitative studyBMJ Open201919
20Health-related quality of life in Parkinson’s: impact of ‘off’ time and stated treatment preferencesQuality of Life Research201618
21ARE VALUE OF INFORMATION METHODS READY FOR PRIME TIME? AN APPLICATION TO ALTERNATIVE TREATMENT STRATEGIES FOR NSTEMI PATIENTSInternational Journal of Technology Assessment in Health Care201316
22Valuing Mobile Health: An Open-Ended Contingent Valuation Survey of a National Digital Health ProgramJMIR MHealth and UHealth201916
23Effectiveness and cost-effectiveness of a loyalty scheme for physical activity behaviour change maintenance: results from a cluster randomised controlled trialInternational Journal of Behavioral Nutrition and Physical Activity201815
24Fractional flow reserve (FFR) versus angiography in guiding management to optimise outcomes in non-ST segment elevation myocardial infarction (FAMOUS-NSTEMI) developmental trial: cost-effectiveness using a mixed trial- and model-based methodsCost Effectiveness and Resource Allocation201514
25The Relative Efficacy and Safety of Mirabegron and OnabotulinumtoxinA in Patients With Overactive Bladder who Have Previously Been Managed With an Antimuscarinic: A Network Meta-analysisUrology201914
26Effectiveness and cost-effectiveness of a physical activity loyalty scheme for behaviour change maintenance: a cluster randomised controlled trialBMC Public Health201613
27Geographic variation of inpatient care costs at the end of lifeAge and Ageing201611
28Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular DiseaseCirculation202211
29Explaining trends in alcohol-related harms in Scotland 1991–2011 (II): policy, social norms, the alcohol market, clinical changes and a synthesisPublic Health201610
30A Systematic Review and Network Meta-Analysis to Evaluate the Comparative Efficacy of Interventions for Unfit Patients with Chronic Lymphocytic LeukemiaAdvances in Therapy201610
31A Decision-Analytic Model to Assess the Cost-Effectiveness of Etelcalcetide vs. CinacalcetPharmacoeconomics201810
32Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopeniaClinicoEconomics and Outcomes Research201810
33Protocol for the economic evaluation of a complex intervention to improve the mental health of maltreated infants and children in foster care in the UK (The BeST? services trial)BMJ Open20189
34Use of methods for specifying the target difference in randomised controlled trial sample size calculations: Two surveys of trialists’ practiceClinical Trials20148
35The SCottish Alcoholic Liver disease Evaluation: A Population-Level Matched Cohort Study of Hospital-Based Costs, 1991-2011PLoS ONE20168
36Modelling Comparative Efficacy of Drugs with Different Survival Profiles: Ipilimumab, Vemurafenib and Dacarbazine in Advanced MelanomaBioDrugs20167
37Potential users’ preferences towards cardiac telemedicine: A discrete choice experiment investigation in SardiniaHealth Policy and Technology20187
38A different animal? Identifying the features of health technology assessment for developers of medical technologiesInternational Journal of Technology Assessment in Health Care20207
39Scottish Keep Well health check programme: an interrupted time series analysisJournal of Epidemiology and Community Health20166
40Cost-effectiveness of financial incentives for smoking cessation in pregnancyAddiction20166
41Using Nominal Group Technique to Identify Key Attributes of Oncology Treatments for a Discrete Choice ExperimentMDM Policy and Practice20195
42A toolkit of methods of development-focused health technology assessmentInternational Journal of Technology Assessment in Health Care20215
43Evaluation of Health in Pregnancy grants in Scotland: a protocol for a natural experimentBMJ Open20144
44Development and validation of a pharmacoeconomic tool for decision making in the implementation of pharmaceutical care for hypertensive patients in the Brazilian public health system (SUS)Procedia Computer Science20174
45Trial of healthy relationship initiatives for the very early years (THRIVE), evaluating Enhanced Triple P for Baby and Mellow Bumps for those with additional social and care needs during pregnancy and their infants who are at higher risk of maltreatment: study protocol for a randomised controlled trialTrials20194
46The Best Services Trial (BeST?): a cluster randomised controlled trial comparing the clinical and cost-effectiveness of New Orleans Intervention Model with services as usual (SAU) for infants and young children entering careTrials20224
47171: ADSCaN: A Randomised Phase II study of Accelerated, Dose escalated, Sequential Chemo-radiotherapy in Non-Small Cell Lung Cancer (NSCLC)Lung Cancer20172
48A criterion-based approach to systematic and transparent comparative effectiveness: a case study in psoriatic arthritisJournal of Comparative Effectiveness Research20192
49Evaluation of Triage Tests When Existing Test Capacity Is Constrained: Application to Rapid Diagnostic Testing in COVID-19Medical Decision Making20212
50Towards transforming community eye care: an observational study and time-series analysis of optometrists’ prescribing for eye disordersPublic Health20212